JNJ vs CRL
By Alex · Tickerpine
Johnson & Johnson vs Charles River Laboratories International, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CRL |
|---|---|---|
| Price | $254.66 | $215.75 |
| Market cap | $613.02B | $10.39B |
| P/E ratio | 29.5 | — |
| ROE | 26.42% | -5.87% |
| Profit margin | 21.83% | -4.58% |
| Revenue growth | 9.90% | 1.20% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 1.45 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CRL in plain English
- JNJ is the bigger company — about 59.0× the market cap of CRL.
- JNJ earns a higher return on equity (26% vs -6%).
- JNJ is growing revenue faster (10% vs 1%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CRL return calculator
See what $1,000 in Charles River Laboratories International, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.